Kraig Biocraft Boosts Spider Silk Production With New Contract

Kraig Biocraft Laboratories Inc., a leading developer of recombinant spider silk-based fibers, announced the signing of a significant production agreement aimed at scaling up its proprietary spider silk technology. This milestone builds upon the successful rollout earlier this year of Kraig Labs’ innovative spider silk production hybrids.

Under the terms of the agreement, Kraig Labs will collaborate closely with silk manufacturers to integrate its advanced spider silk production technology into existing facilities and networks.

The recent expansion of additional production facilities marks a pivotal step in the company’s strategy to enhance spider silk production capabilities.

Kim Thompson, Founder and CEO of Kraig Labs, commented, “We are taking substantial strides towards establishing commercial-scale spider silk manufacturing. This agreement underscores our commitment to expanding our production footprint and capacity. We remain dedicated to embracing innovation, managing strategic risks, and capitalizing on the vast potential of commercial spider silk applications.”